Pagani, O., Walley, B., Fleming, G., M, C., I, L., H.L, G., . . . P.A., F. (2023). Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.
Citación estilo ChicagoPagani, O., et al. Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials. 2023.
Cita MLAPagani, O., et al. Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials. 2023.
Precaución: Estas citas no son 100% exactas.